Ethos Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.39M Buy
2,068
+358
+21% +$422K 1.6% 19
2026
Q2
$2.05M Buy
+1,710
New +$1.75M 1.46% 23

Other funds holding LLY

Ethos Capital Management's LLY Position: Q3 2026 in Review

Ethos Capital Management increased its Eli Lilly (LLY) stake by 21% in Q3 2026, buying an estimated $422K and bringing the position to 2,068 shares worth $2.39M. The position accounts for 1.6% of the portfolio, ranked #19.

Ethos Capital Management first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. 2,535 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Ethos Capital Management held 2,068 shares of Eli Lilly worth $2.39M as of Q3 2026.
  • Ethos Capital Management bought 358 Eli Lilly shares in Q3 2026, an estimated $422K.
  • Eli Lilly made up 1.6% of Ethos Capital Management's portfolio in Q3 2026, its #19 holding.
  • Ethos Capital Management first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
  • 2,535 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Ethos Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.